Baird Medical Investment Holdings Limited
BDMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $37,037 | $31,458 | $35,091 | $27,722 |
| % Growth | 17.7% | -10.4% | 26.6% | – |
| Cost of Goods Sold | $4,383 | $4,227 | $7,054 | $4,544 |
| Gross Profit | $32,654 | $27,230 | $28,037 | $23,178 |
| % Margin | 88.2% | 86.6% | 79.9% | 83.6% |
| R&D Expenses | $6,174 | $4,275 | $3,859 | $1,040 |
| G&A Expenses | $5,903 | $8,547 | $6,961 | $6,651 |
| SG&A Expenses | $9,964 | $11,094 | $10,546 | $10,221 |
| Sales & Mktg Exp. | $4,061 | $2,547 | $3,585 | $3,570 |
| Other Operating Expenses | $1,200 | $0 | $0 | $0 |
| Operating Expenses | $17,339 | $15,369 | $13,030 | $9,758 |
| Operating Income | $15,315 | $11,862 | $13,632 | $11,917 |
| % Margin | 41.4% | 37.7% | 38.8% | 43% |
| Other Income/Exp. Net | -$1,228 | $497 | $890 | $688 |
| Pre-Tax Income | $14,087 | $12,359 | $14,522 | $12,606 |
| Tax Expense | $1,489 | $1,701 | $1,747 | $2,423 |
| Net Income | $12,453 | $10,546 | $12,569 | $11,677 |
| % Margin | 33.6% | 33.5% | 35.8% | 42.1% |
| EPS | 0.49 | 0.41 | 0.022 | -0.024 |
| % Growth | 19.5% | 1,789.4% | 189.7% | – |
| EPS Diluted | 0.49 | 0.41 | 0.022 | -0.024 |
| Weighted Avg Shares Out | 25,555 | 7,584 | 6,286 | 7,188 |
| Weighted Avg Shares Out Dil | 25,628 | 7,584 | 7,188 | 7,188 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $9 | $2 |
| Interest Expense | $577 | $284 | $299 | $154 |
| Depreciation & Amortization | $1,507 | $1,014 | $1,470 | $1,400 |
| EBITDA | $16,171 | $12,876 | $16,291 | $14,159 |
| % Margin | 43.7% | 40.9% | 46.4% | 51.1% |